Comparison of the performance of the PANArray™ HPV test and DNA chip test for genotyping of human papillomavirus in cervical swabs

Biochip Journal

Volumn 4, Issue 3, 2010, Pages 167-172

  Song, Hye Jong ^a   Lee, Jeong Won ^a   Kim, Byoung Gie ^a   Song, Sang Yong ^a   Bae, Duk Soo ^a   Kim, Dae Shick ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

HPV genotyping; Human papillomavirus (HPV); PNA; PNA microarray

Indexed keywords

COMPUTER VIRUSES; CYTOLOGY; PATIENT TREATMENT; VIRUSES;

CERVICAL CARCINOMA; DNA CHIP; GENOTYPING; HIGHLY SENSITIVE; HUMAN PAPILLOMAVIRUS; MEDICAL CENTER; PNA; PNA MICROARRAY; SAMSUNG; SEQUENCING ANALYSIS; STATISTICALLY SIGNIFICANT DIFFERENCE;

DNA;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 79959752817     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-010-4301-y     Document Type: Article

References (11)

1. Huang, S. et al. Principles and analytical performance of abbott real time high risk HPV test. J. Clin. Virol. 45 Suppl 1, S13-17 (2009).
2. Huang, S. et al. Clinical performance of abbott real time high risk HPV test for detection of high-grade cervical intraepithelial neoplasia in women with abnormal cytology. J. Clin. Virol. 45 Suppl 1, S19-23 (2009).
3. Schenk, T. et al. Performance of a polymer-based DNA chip platform in detection and genotyping of human papillomavirus in clinical samples. J. Clin. Microbiol. 47, 1428-1435 (2009).
4. Cuzick, J. et al. Overview of human papillomavirusbased and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26 Suppl 10, K29-41 (2008).
5. Guo, M. et al. Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results. Mod. Pathol. 21, 1037-1043 (2008).
6. Huh, W., Einstein, M.H., Herzog, T.J. & Franco, E.L. What is the role of HPV typing in the United States now and in the next five years in a vaccinated population? Gynecol. Oncol. 117, 481-485 (2010).
7. Jones, J., Powell, N.G., Tristram, A., Fiander, A.N. & Hibbitts, S. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set. J. Clin. Virol. 45, 100-104 (2009).
8. Choi, J.J., Kim, C. & Park, H. Peptide nucleic acidbased array for detecting and genotyping human papillomaviruses. J. Clin. Microbiol. 47, 1785-1790 (2009).
9. Molijn, A., Kleter, B., Quint, W. & van Doorn, L.J. Molecular diagnosis of human papillomavirus (HPV) infections. J. Clin. Virol. 32 Suppl 1, S43-51 (2005).
10. Bae, J.H., Kim, C.J., Park, T.C., Namkoong, S.E. & Park, J.S. Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int. J. Gynecol. Cancer 17, 1271-1277 (2007).
11. Cho, N.H. et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am. J. Obstet. Gynecol. 188, 56-62 (2003).